← Back to Search

Birth Control Pills for Hand and Wrist Injuries

N/A
Recruiting
Research Sponsored by University of Central Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Right handed males and females
Ages 18-35 years
Must not have
Current depression or anxiety
History of heart attack
Timeline
Screening 3 weeks
Treatment Varies
Follow Up grip strength will be tested weekly for at least 3 weeks (i.e., baseline, post-immobilization, post 1 week recovery). testing will continue every week following immobilization until grip strength has returned to baseline levels.
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to understand why females tend to get more hand and wrist injuries compared to males in sports. The study will look at the impact of hormones, such as those from birth control, on muscle

Who is the study for?
This trial is for females who are either using monophasic oral contraceptives or not, and males. It aims to understand the impact of hormones on hand/wrist injury risk by studying muscle strength and control during a week of immobilization.
What is being tested?
The study tests how one week of wrist/hand immobilization affects muscle strength and neuromuscular activation in three groups: women on birth control pills, women not on them, and men.
What are the potential side effects?
Since this trial involves immobilization without medication or invasive procedures, side effects may include temporary discomfort, stiffness or weakness in the immobilized hand/wrist.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am right-handed.
Select...
I am between 18 and 35 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently experiencing depression or anxiety.
Select...
I have had a heart attack before.
Select...
I have a history of arthritis.
Select...
I or my family have a history of blood clots.
Select...
I have had a stroke in the past.
Select...
I have difficulty controlling my muscles.
Select...
I have had cancer in the past.
Select...
My periods are irregular and I don't use birth control pills.
Select...
I experience pain or discomfort in my upper limbs.
Select...
I have had an injury, pain, or surgery in my elbow, wrist, or hand.
Select...
I have a neuromuscular condition like MS, ALS, or Parkinson's.
Select...
I have not had a period for 3+ cycles or my cycles are very irregular.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~grip strength will be tested weekly for at least 3 weeks (i.e., baseline, post-immobilization, post 1 week recovery). testing will continue every week following immobilization until grip strength has returned to baseline levels.
This trial's timeline: 3 weeks for screening, Varies for treatment, and grip strength will be tested weekly for at least 3 weeks (i.e., baseline, post-immobilization, post 1 week recovery). testing will continue every week following immobilization until grip strength has returned to baseline levels. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Grip Strength
Secondary study objectives
Muscle activation

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Wrist/hand immobilizationExperimental Treatment1 Intervention
Participants will have their wrist and hand immobilized using a rigid splint continuously for 7 days. The splint will restrict all wrist and hand movement and must be worn at all times for the full 7 day period, and may only be removed under supervision of the research participants.

Find a Location

Who is running the clinical trial?

University of Central FloridaLead Sponsor
92 Previous Clinical Trials
1,120,216 Total Patients Enrolled
~0 spots leftby Dec 2024